Eric J. Rubin, Oladapo O. Yeku, Stephen Morrissey. "NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors." New England Journal of Medicine (2025). https://doi.org/10.1056/nejme2411486